Today we'll do a simple run through of a valuation method used to estimate the attractiveness of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) as an investment opportunity by taking the expected future cash flows and discounting them to their present value.View our latest analysis for BioMarin Pharmaceutical  We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows.